Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11), versus ($0.05) reported last year. Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.16 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• JPMorgan Upgrades Tyson (TSN) to Overweight
• Ready Capital prices $225M in new notes, redeems $350M due 2026